Korea Arlico PharmLtd Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Hang-Gu Lee
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 39.2% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?
Mar 24
Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?
Mar 02Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares
Feb 12
What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?
Jan 25Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?
Jan 04Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?
Dec 16Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?
Nov 25CEO
Hang-Gu Lee (62 yo)
no data
Tenure
Mr. Hang-Gu Lee is Chief Executive Officer of Korea Arlico Pharm Co.,Ltd.